Literature DB >> 18095087

Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs).

Hideaki Hanaki1, Yuuji Koide, Hiroaki Yamazaki, Ryoichi Kubo, Tomota Nakano, Koichiro Atsuda, Keisuke Sunakawa.   

Abstract

HMRZ-86 was designed as a new chromogenic cephalosporin to detect extended-spectrum beta-lactamases (ESBLs) and similar evolved beta-lactamases, such as metallo-beta-lactamases, derepressed AmpC, and extended oxacillinase. We report here our investigation of the kinetic parameters of several types of beta-lactamases to show the enzymatic characteristics of HMRZ-86. The Michaelis constant (Km values of HMRZ-86 for ESBLs were twice to three and half times as high as those of nitrocefin, and the maximum velocity (Vmax) was one-fifth that of nitrocefin. The Km and Vmax of HMRZ-86 for AmpC were both smaller than those of nitrocefin. The kinetic parameters of HMRZ-86 for metallo beta-lactamase (MBL) were very variable, depending on the type of buffer solution used and the concentration of zinc ions. For MBL, the Km values of HMRZ-86 were higher than those of nitrocefin, but the Vmax values were almost the same as those of nitrocefin. Although the chemical structure of HMRZ-86 is similar to that of nitrocefin, we think the enzymatic reactivities of the two entities for beta-lactamases are very different.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095087     DOI: 10.1007/s10156-007-0563-2

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  5 in total

1.  Evaluation of the βLACTA test, a novel commercial chromogenic test for rapid detection of ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates.

Authors:  Terry Laurent; Te-Din Huang; Pierre Bogaerts; Youri Glupczynski
Journal:  J Clin Microbiol       Date:  2013-04-10       Impact factor: 5.948

2.  ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae.

Authors:  Mohamed Ramadan El-Jade; Marijo Parcina; Ricarda Maria Schmithausen; Christoph Stein; Alina Meilaender; Achim Hoerauf; Ernst Molitor; Isabelle Bekeredjian-Ding
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

3.  Rapid detection of β-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic βLacta test.

Authors:  María Isabel Morosini; María García-Castillo; Marta Tato; Desirèe Gijón; Aránzazu Valverde; Patricia Ruiz-Garbajosa; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

4.  Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae.

Authors:  Aurélie Renvoisé; Dominique Decré; Rishma Amarsy-Guerle; Te-Din Huang; Christelle Jost; Isabelle Podglajen; Laurent Raskine; Nathalie Genel; Pierre Bogaerts; Vincent Jarlier; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2013-09-25       Impact factor: 5.948

5.  Early detection of extended-spectrum β-lactamase from blood culture positive for an Enterobacteriaceae using βLACTA test.

Authors:  Guy Prod'hom; Christian Durussel; Dominique Blanc; Antony Croxatto; Gilbert Greub
Journal:  New Microbes New Infect       Date:  2015-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.